Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

Clicks: 344
ID: 120122
1995
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Respiratory syncytial virus (RSV) infections in adult BMT recipients are frequently complicated by fatal pneumonias. Therapy of RSV pneumonia with aerosolized ribavirin alone has been reported to be associated with a 70% mortality rate. Because immune globulin therapy has been reported to be benefic …
Reference Key
e1995bonecombination Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Whimbey E;Champlin RE;Englund JA;Mirza NQ;Piedra PA;Goodrich JM;Przepiorka D;Luna MA;Morice RC;Neumann JL;;
Journal bone marrow transplantation
Year 1995
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8535312
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult male middle aged Clinical Trial immunoglobulins intravenous / therapeutic use* inhalation Survival Analysis respiratory syncytial viruses / isolation & purification* drug therapy combination r e champlin e whimbey antiviral agents / therapeutic use* ribavirin / administration & dosage ribavirin / therapeutic use* respiratory syncytial virus infections / drug therapy* respiratory syncytial virus infections / mortality cross infection / mortality bone marrow transplantation / adverse effects* respiratory syncytial virus infections / etiology cross infection / drug therapy* pmid:8535312 j l neumann

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.